Spectral AI - Class A opened lower at $1.55, compared with its previous close of $1.57. In the last trading session, the stock traded between $1.49 and $1.55. It showed a downward intraday trend.
An investment of $100 made 4 years ago in Spectral AI - Class A is now worth
$ 29.50
resulting in a loss of
$ 70.50 (70.50%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
$-0.04 (-2.48%)
Day High
$1.55
Day Low
$1.49
Day Open
$1.55
Prev Close
$1.57
Volume
51,462
1W Return
1.73%
1M Return
-3.10%
3M Return
1.73%
6M Return
-21.08%
1Y Return
-29.77%
Market Cap ($ Mn)
49
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-1,293.29%
EPS (TTM)
$-0.13
1 Week
1.73%
1 Month
-3.10%
3 Months
1.73%
6 Months
-21.08%
9 Months
-15.41%
Spectral AI to present DeepView burn wound data at ACS Congress 2026
Spectral AI will present DeepView validation data at ACS Clinical Congress 2026. Presentation led by Dr. James H. Holmes IV of Atrium Health Wake Forest Baptist. DeepView received FDA De Novo Classification in May 2026. System processes burn wound assessments in approximately 20 to 25 seconds. Company aims to expand DeepView adoption beyond specialized burn centers.
1mo agoSpectral AI showcases DeepView burn system at Southern Regional conference
Spectral AI showcased its DeepView System at the Southern Regional Burn Conference in September 2026. KOL presentations highlighted AI's role in improving physician accuracy for detecting non-healing burn wounds. The system received FDA De Novo Classification in May 2026 and UKCA authorization in February 2024. DeepView processes images in approximately 20 to 25 seconds using a database of over 340 billion pixels.
1mo agoSpectral AI Latest Results: Sales guidance affirmed at $18.500M
Spectral AI reaffirms FY2026 sales guidance at $18.500 million, slightly below the $18.538 million estimate. The unchanged outlook reflects stable operational expectations despite missing consensus by a marginal amount.
2mo agoSpectral AI Q2 EPS beats estimate, sales miss consensus
Spectral AI's Q2 results show an EPS beat driven by non-cash warrant gains, despite a significant miss on revenue estimates due to declining government contract reimbursements. The company maintains strong cash reserves ahead of commercial launch.
2mo agoSpectral AI Q2 Results: Company schedules earnings call for Aug 11
Spectral AI, Inc. will report Q2 2026 results on August 11, 2026, after market close. A conference call is scheduled for 5:00 pm ET, with dial-in numbers provided for US and international investors. The company focuses on AI-driven medical diagnostics for wound care.
3mo agoSpectral AI to present DeepView System at BBA Annual Conference
Spectral AI, Inc. is set to participate in the 2026 British Burn Association Annual Meeting in Nottingham, England, from June 17-19, 2026. The company will feature its DeepView System, which recently gained FDA De Novo Classification and UKCA authorization. Spectral AI anticipates launching its first commercial sales of the system by the end of 2026.
4mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $104.57 | +1.88% | $1,80,946.15M | 36.28 | |
| $448.76 | +1.03% | $1,55,559.96M | 42.73 | |
| $97.11 | +2.46% | $1,24,220.20M | 24.46 | |
| $311.75 | +2.55% | $1,19,578.88M | 34.27 | |
| $42.69 | +0.61% | $61,867.63M | 18.96 | |
| $94.44 | +2.90% | $54,435.22M | 53.70 | |
| $198.34 | +1.63% | $54,025.24M | 44.07 | |
| $252.83 | +1.06% | $35,557.76M | 23.04 | |
| $76.42 | +0.79% | $34,552.39M | 16.49 | |
| $71.13 | +1.86% | $34,384.24M | 54.55 | |
| $79.93 | +1.67% | $30,162.46M | 36.04 | |
| $416.67 | +3.23% | $29,323.57M | 43.21 |
An investment of $100 made 4 years ago in Spectral AI - Class A is now worth
$ 29.50
resulting in a loss of
$ 70.50 (70.50%)
Note: Past profits do not guarantee future returns.
